Abstract:Cytochomosome P450 enzymes (CYP) are heme-containing monooxygenases responsible for oxidative metabolism of many exogenous and endogenous compounds including drugs. The species difference of CYP limits the extent to which data obtained from animals can be translated to humans in pharmacodynamics or pharmacokinetics studies. Transgenic expression of human CYP in animals lacking or with largely reduced endogenous CYP counterparts is recognized as an ideal strategy to correct CYP species difference. CYP3A is the most abundant CYP subfamily both in human and mammals. In this study, we designed a microRNA-based shRNA (miR-shRNA) simultaneously targeting four members of mouse CYP3A subfamily (CYP3A11, CYP3A16, CYP3A41 and CYP3A44), and transgenic mice expressing the designed miR-shRNA were generated by lentiviral transgenesis. Results showed that the CYP3A expression level in transgenic mice was markedly reduced compared to that in wild type or unrelated miR-shRNA transgenic mice, and was inversely correlated to the miR-shRNA expression level. The CYP3A expression levels in transgenic offspring of different generations were also remarkably lower compared to those of controls, and moreover the inhibition rate of CYP3A expression remained comparable over generations. The ratio of the targeted CYP3A transcriptional levels was comparable between knockdown and control mice of the same gender as detected by RT-PCR DGGE analysis. These data suggested that transgenic miR-shRNA suppressed CYP3A expression in a dose-dependent and inheritable manner, and transcriptional levels of the targeted CYP3As were suppressed to a similar extent. The observed knockdown efficacy was further confirmed by enzymatic activity analysis, and data showed that CYP3A activities in transgenic mice were markedly reduced compared to those in wild-type or unrelated miR-shRNA transgenic controls (1.11 +/- 0.71 vs 5.85 +/- 1.74, 5.9 +/- 2.4; P<0.01). This work laid down a foundation to further knock down the remaining murine CYP3As or CYPs of other subfamilies, and a basis to generate CYP knockdown animals of other species.

Adapted Resistance To The Knockdown Effect Of Shrna-Derived Srsf3 Sirnas In Mouse Littermates

Effective Silencing Of Sry Gene With Rna Interference In Developing Mouse Embryos Resulted In Feminization Of Xy Gonad

Transgenic RNA interference in mice.

Effective Silencing ofSryGene with RNA Interference in Developing Mouse Embryos Resulted in Feminization of XY Gonad

Tissue-Specific RNAi Expression in Transgenic Mice

20 RNA Interference in Mouse Models

Lentiviral Transgenic Microrna-Based Shrna Suppressed Mouse Cytochromosome P450 3a (Cyp3a) Expression In A Dose-Dependent And Inheritable Manner

High Doses of Sirnas Induce Eri-1 and Adar-1 Gene Expression and Reduce the Efficiency of RNA Interference in the Mouse

RNA Interference in Mouse Models

A CRISPR/RfxCas13d-mediated strategy for efficient RNA knockdown in mouse embryonic development

Conditional Knockdown of Fgfr2 in Mice Using Cre-LoxP Induced RNA Interference

A pipeline for the generation of shRNA transgenic mice

RNAi-based Conditional Gene Knockdown in Mice Using a U6 Promoter Driven Vector

Drug-inducible Synergistic Gene Silencing with Multiple Small Hairpin RNA Molecules for Gene Function Study in Animal Model

Construction and Gene Silencing Evaluation of S6K1 Shrna Gene Recombinant Adenovirus

A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference

shRNA Transcribed by RNA Pol II Promoter Induce RNA Interference in Mammalian Cell

Developing a Versatile Shotgun Cloning Strategy for Single-Vector-Based Multiplex Expression of Short Interfering RNAs (sirnas) in Mammalian Cells

Stable suppression of gene expression by RNAi in mammalian cells

The Application of RNAi Technology in Transgenic Mice